What is NDC 70166-355?

70166-355 is the product NDC for Mupirocin, Mupirocin 20 mg/g ointment, listed with the FDA by Lohxa. It has 2 package NDCs, shown above in 10- and 11-digit form.

Lohxa, NDC labeler code 70166. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Mupirocin?

42 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Mupirocin NDC 70166-355 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70166-355Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70166-0355Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70166-355-10	7016603551070166035510	100 TUBE in 1 CARTON (70166-355-10) / 1 g in 1 TUBEMarketed from May 26, 2018
70166-355-50	7016603555070166035550	50 TUBE in 1 CARTON (70166-355-50) / 1 g in 1 TUBEMarketed from Mar 25, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Mupirocin
Generic name (nonproprietary): mupirocin
Active ingredients: Mupirocin — 20 mg/g
Dosage form: Ointment
Route: Topical
Labeler: LohxaNDC labeler code 70166
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065170
Marketing start: May 26, 2018
Listing expires: Dec 31, 2026
Other FDA classes: RNA Synthetase Inhibitors (Mechanism)
Identifiers: Product ID 70166-355_313090ef-ad58-1103-e063-6394a90a7d75SPL ID 313090ef-ad58-1103-e063-6394a90a7d75SPL set ID 6d59e35c-b262-7940-e053-2991aa0a8908RxCUI 106346UNII D0GX863OA5
Pharmacologic class: RNA Synthetase Inhibitor Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470166035510 followed by a unit qualifier and the quantity

Package 70166-0355-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 25, 2025.

Indications (excerpt from the label)

Mupirocin Ointment USP, 2% is indicated for the topical treatment of impetigo due to susceptible isolates of Staphylococcus aureus (S. aureus) and Streptococcus pyogenes (S. pyogenes) . Mupirocin ointment is an RNA synthetase inhibitor antibacterial indicated for the topical treatment of impetigo due to susceptible isolates of Staphylococcus aureus and Streptococcus pyogenes . ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70166-355

What is NDC 70166-355?: 70166-355 is the product NDC for Mupirocin, Mupirocin 20 mg/g ointment, listed with the FDA by Lohxa. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Mupirocin.
What is the active ingredient?: Mupirocin.
Who is the labeler?: Lohxa, NDC labeler code 70166. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Mupirocin?: 42 other product NDCs are listed under this name. See all Mupirocin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Mupirocin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Mupirocin	Mupirocin calcium 20 mg/g	CreamTopical	Zydus Lifesciences Limited	70771-1981	70771-1981-0170771-1981-02
Mupirocin	Mupirocin calcium 20 mg/g	CreamTopical	Viona Pharmaceuticals Inc	72578-130	72578-0130-0172578-0130-06
Mupirocin	Mupirocin 20 mg/g	OintmentTopical	PAI Holdings, LLC dba PAI Pharma	0121-1076	00121-1076-50
Mupirocinmupirocin ointment	Mupirocin 20 mg/g	OintmentTopical	Kesin Pharma Corporation	81033-032	81033-0032-5081033-0032-99
Mupirocin	Mupirocin 20 mg/g	OintmentTopical	Encube Ethicals, Inc.	21922-073	21922-0073-0421922-0073-0521922-0073-25
Mupirocin	Mupirocin 20 mg/g	OintmentTopical	Redpharm Drug	67296-2211	67296-2211-01
Mupirocin	Mupirocin calcium 20 mg/g	CreamTopical	Alembic Pharmaceuticals Limited	46708-624	46708-0624-1546708-0624-30
mupirocin	Mupirocin 20 mg/g	OintmentTopical	St. Mary's Medical Park Pharmacy	60760-960	60760-0960-22
mupirocin	Mupirocin 20 mg/g	OintmentTopical	Preferred Pharmaceuticals Inc.	68788-8642	68788-8642-02
Mupirocin	Mupirocin 20 mg/g	OintmentTopical	Preferred Pharmaceuticals Inc.	68788-8534	68788-8534-02

All 43 Mupirocin NDCs

Other NDCs under ANDA 065170

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065170
Product	Strength	Form · route	Labeler	Product NDC
Mupirocin	Mupirocin 20 mg/g	OintmentTopical	PAI Holdings, LLC dba PAI Pharma	0121-1076
Mupirocin	Mupirocin 20 mg/g	OintmentTopical	AvPAK	50268-568
Mupirocin	Mupirocin 20 mg/g	OintmentTopical	Sun Pharmaceutical Industries, Inc.	51672-1312
Mupirocin	Mupirocin 20 mg/g	OintmentTopical	Proficient Rx LP	63187-151
Mupirocin	Mupirocin 20 mg/g	OintmentTopical	NuCare Pharmaceuticals,Inc.	68071-4321
Mupirocin	Mupirocin 20 mg/g	OintmentTopical	Advanced Rx Pharmacy of Tennessee, LLC	80425-0254
Mupirocin	Mupirocin 20 mg/g	OintmentTopical	Sportpharm LLC	85766-207